Trypan blue

Trypan blue staining and cell counting
http://bioserv.fiu.edu

Growing Cells in Culture
http://www.science.marshall.edu

Basics of Cell Culture
http://www.pitt.edu

Flow Cytometry
http://www.cyto.purdue.edu

Cell viability studies
Sepideh Khoshnevis
http://dddas.ices.utexas.edu

IL-12 enhances the generation of tumour antigen-specific Th1 CD4+ T-cells during ex vivo expansion
Knutson, K.L., M.L. Disis
http://snhs-plin.barry.edu

Cytotoxicity: Role in disease and homeostasis
Dr. Ronald B. Smeltz
http://www.courses.vcu.edu

Tissue Culture Methodology
http://www.kean.edu

Mechanism of hsp70i Gene Bookmarking
http://www.biochemistry.uab.edu

Use of FACS in the Isolation and Characterization of Gastrointestinal Neuroendocrine Cells
Mark Kidd, Ph.D.
http://medicine.yale.edu

Case Study Pathogenic Bacteriology
http://instructional1.calstatela.edu/

Hypoxia Activates the K-Ras Proto-Oncogene to Stimulate Angiogenesis and Inhibit Apoptosis in Colon Cancer Cells
Min Zeng, Hirotoshi Kikuchi, Maria S. Pino, Daniel C. Chung
http://sdjohnston.faculty.noctrl.edu/

Basic techniques of tissue culture
Rachel Henry
https://medschool.mc.vanderbilt.edu


681 Published articles articles on Trypan blue

1. Trypan blue staining to determine vaginal exposure in two types of plastic vaginal applicators containing two different microbicide formulations.
2. Trypan blue staining of filtering bleb in eyes with operate trabeculectomy.
3. A screening method for β-glucan hydrolase employing Trypan Blue-coupled β-glucan agar plate and β-glucan zymography.
4. Unintentional staining of the posterior lens capsule with trypan blue dye during phacoemulsification: case report.
5. Bactericidal effect of trypan blue and fluorescein sodium in ophthalmic practice.
6. Comparison of capsulorhexis resistance to tearing with and without trypan blue dye using a mechanized tensile strength model.
7. The use of trypan blue dye for strabismus reoperations, surgery complications, and especially for the identification and recovery of a "slipped" or "lost" extraocular muscle.
8. Eye candy world: don't think, emote! Strabology surgery for nystagmus; slip? Trypan blue; globe fixes.
9. Oblique illumination and trypan blue to enhance visualization through corneal scars in cataract surgery.
10. Confirming and Establishing Patency of Glaucoma Drainage Devices Using Trypan Blue.
11. Viability assessment of fresh and frozen/thawed isolated human follicles: reliability of two methods (Trypan blue and Calcein AM/ethidium homodimer-1).
12. Trypan blue dye enters viable cells incubated with the pore-forming toxin HlyII of Bacillus cereus.
13. Trypan Blue staining method for quenching the autofluorescence of RPE cells for improving protein expression analysis.
14. The trypanocidal drug suramin and other trypan blue mimetics are inhibitors of pyruvate kinases and bind to the adenosine site.
15. Retinal pigment epithelial changes after trypan blue-assisted internal limiting membrane peeling for idiopathic macular hole.
16. A comparison of brilliant blue G, trypan blue, and indocyanine green dyes to assist internal limiting membrane peeling during macular hole surgery.
17. Anterior lens capsule has more affinity to trypan blue in patients with pseudoexfoliation.
18. Trypan blue dye for anterior segment surgeries.
19. Methyl blue and aniline blue versus patent blue and trypan blue as vital dyes in cataract surgery: capsule staining properties and cytotoxicity to human cultured corneal endothelial cells.
20. Cell viability analysis using trypan blue: manual and automated methods.
21. Comparative toxicology of trypan blue, brilliant blue G, and their combination together with polyethylene glycol on human pigment epithelial cells.
22. In vivo safety of trypan blue use in vitreoretinal surgery.
23. Trypan blue to assess Baerveldt tube patency after repair of its obstruction.
24. Two cases of toxic anterior segment syndrome from generic trypan blue.
25. Evaluation of trypan-blue and indocyanine-green staining of iris prostheses.
26. Inadvertent vitreous staining with trypan blue in pseudoexfoliation syndrome.
27. Subretinal migration of trypan blue during macular hole and epiretinal membrane peel: an observational case series. Is there a safer method?
28. Visualization of acupuncture meridians in the hypodermis of rat using Trypan blue.
29. Trypan Blue capsulorhexis.
30. Functional and structural effect of intravitreal indocyanine green, triamcinolone acetonide, trypan blue, and brilliant blue g on rat retina.
31. Double peel using triamcinolone acetonide and trypan blue in the management of myopic macular hole with retinal detachment: a case-control study.
32. Trypan blue staining for capsulorhexis: ultrastructural effect on lens epithelial cells and capsules.
33. Normal physiological and pathophysiological effects of trypan blue on the retinas of albino rabbits.
34. Use of heavy Trypan blue in macular hole surgery.
35. Electrophysiological retinal pigment epithelium changes observed with indocyanine green, trypan blue and triamcinolone.
36. Ultrastructure and retinal imaging of internal limiting membrane: a clinicopathologic correlation of trypan blue stain in macular hole surgery.
37. Ultrastructure and retinal imaging of epiretinal membrane: a clinicopathologic correlation of trypan blue staining in epiretinal membrane surgery.
38. Retinal nerve fiber layer thickness evaluation after trypan blue-assisted macular surgery.
39. Cytotoxicity evaluation of two root canal sealers and a commercial calcium hydroxide paste on THP1 cell line by Trypan Blue assay.
40. Inadvertent use of water-based ink instead of trypan blue in cataract surgery.
41. Trypan blue selective staining using whole blood for internal limiting membrane peeling during macular hole corrective surgery.
42. Does the use of trypan blue during phacoemulsification affect the intraocular pressure?
43. Use of trypan blue stain in endothelial keratoplasty.
44. An outbreak of postoperative gram-negative bacterial endophthalmitis associated with contaminated trypan blue ophthalmic solution.
45. Visualizing the network of Bonghan ducts in the omentum and peritoneum by using Trypan blue.
46. Effect of trypan blue staining on the elastic modulus of anterior lens capsules of diabetic and nondiabetic patients.
47. Evaluation of trypan-blue toxicity in macular hole surgery with electroretinography.
48. Improved sensitivity of trypan blue dye exclusion assay with Ni2+ or Co2+ salts.
49. Trypan blue as a fluorochrome for confocal laser scanning microscopy of arbuscular mycorrhizae in three mangroves.
50. Effect of trypan blue on the elasticity of the human anterior lens capsule.
51. Use of trypan blue dye during conversion of deep anterior lamellar keratoplasty to penetrating keratoplasty.
52. Current concepts of trypan blue in chromovitrectomy.
53. Comparative quantification of ingress of trypan blue into the anterior chamber after microcoaxial, standard coaxial, and bimanual phacoemulsification: randomized clinical trial.
54. Trypan blue exclusion test of cell viability.
55. Atrophy of the retinal pigment epithelium following vitrectomy with trypan blue.
56. Alkaline Trypan Blue as a stain for superficial fungi.
57. Inadvertent corneal stromal staining by trypan blue during cataract surgery.
58. Phenotypic analysis of Arabidopsis mutants: trypan blue stain for fungi, oomycetes, and dead plant cells.
59. Trypan blue capsule staining for phacoemulsification in white cataract.
60. Systematic evaluation of ICG and trypan blue related effects on ARPE-19 cells in vitro.
61. Non-infectious endophthalmitis associated with trypan blue use in cataract surgery.
62. Heavy trypan blue staining of epiretinal membranes: an alternative to infracyanine green.
63. Effect of trypan blue on lens epithelial cells in human eyes having capsulorhexis.
64. Indocyanine green and trypan blue: intracellular uptake and extracellular binding by human retinal pigment epithelial cells.
65. Effects of subretinal injection of patent blue and trypan blue in rabbits.
66. Effect of stromal hydration of clear corneal incisions: quantifying ingress of trypan blue into the anterior chamber after phacoemulsification.
67. Traumatic cataract surgery assisted by trypan blue.
68. Internal limiting membrane peeling with indocyanine green or trypan blue in macular hole surgery: a randomized trial.
69. Use of trypan blue staining to assess the quality of ovarian cryopreservation.
70. Effects of subretinal injections of indocyanine green, trypan blue, and glucose in rabbit eyes.
71. Clear corneal incision with trypan-blue-coated blades.
72. Trypan blue-assisted posterior tenectomy of the superior oblique.
73. Trypan-blue-assisted "re-rhexis" for smooth in-the-bag exchange of a calcified intraocular lens.
74. Identification of retinal breaks using subretinal trypan blue injection.
75. Trypan-blue-assisted anterior continuous curvilinear capsulorhexis in a case of ocular pemphigoid.
76. Effect of trypan blue staining on the density and viability of lens epithelial cells in white cataract.
77. Trypan blue-assisted neodymium:YAG laser treatment for overfiltering bleb.
78. Trypan blue to aid visualization of the vitreous during anterior segment surgery.
79. Differential trypan blue staining of tumor cells for the determination of apoptosis.
80. Hypothermia of 8 degrees C protects cultured retinal pigment epithelial cells and retinal ganglion cells against trypan blue toxicity.
81. Efficacy of trypan blue in posterior capsulorhexis with optic capture in pediatric cataracts ISRCTN48221688.
82. Staining the anterior capsule with indocyanine green or trypan blue for capsulorhexis in eyes with white cataract.
83. Unintentional staining of lens posterior capsule with trypan blue during extracapsular cataract extraction: case report.
84. Risk of contamination of trypan blue dye after first use.
85. Hypothermia protects cultured human retinal pigment epithelial cells against trypan blue toxicity.
86. Trypan blue-assisted high-volume cataract surgery in a peri-urban eye hospital in India.
87. Subretinal trypan blue migration during epiretinal membrane peeling.
88. Comparison of the efficacy of live and autoclaved mycelium of Trichoderm harzianum on the removal of trypan blue.
89. Use of trypan blue for penetrating keratoplasty.
90. In vitro quantitative determination of ophthalmic irritancy by the chorioallantoic membrane test with trypan blue staining as alternative to eye irritation test.
91. Trypan blue-associated retinal toxicity post complicated cataract surgery.
92. Trypan-blue- and endoillumination-assisted phacoemulsification in eyes with vitreous hemorrhage during combined cataract and vitreous surgery.
93. Additional uses of trypan blue staining during cataract surgery.
94. Trypan blue staining of the anterior capsule: the one-drop technique.
95. Trypan blue staining of antiproliferative agents for trabeculectomy surgery and bleb needling.
96. Neurotoxic effects of trypan blue on rat retinal ganglion cells.
97. Trypan blue exclusion principle in the evaluation of fibroblast attachment in vitro using V79 cells on the conditioned root surface.
98. Trypan blue identifies antimetabolite treatment area in trabeculectomy.
99. Staining of filtering bleb with trypan blue during phacoemulsification.
100. A prospective study on trypan blue capsule staining under air vs under viscoelastic.
101. Staining of the tenon capsule with trypan blue during enucleation surgery.
102. Efficacy of 0.15% trypan blue for staining and removal of the internal limiting membrane, epiretinal membranes, and the posterior hyaloid during pars plana vitrectomy.
103. Photodynamic actions of indocyanine green and trypan blue on human lens epithelial cells in vitro.
104. Vitreous surgery with trypan blue staining of membranes in PVR retinal detachment surgery.
105. Visualization of conjunctival cyst using Healon V and trypan blue.
106. Establishment and optimization of a flow cytometric method for evaluation of viability of CD34+ cells after cryopreservation and comparison with trypan blue exclusion staining.
107. Safety of trypan blue 1% and indocyanine green 0.5% in assisting visualization of anterior capsule during phacoemulsification in mature cataract.
108. Anterior capsular staining with trypan blue for capsulorhexis in mature and hypermature cataracts. A preliminary study.
109. Role of trypan blue in epiretinal membrane surgery.
110. Evaluation of trypan blue toxicity in idiopathic epiretinal membrane surgery with macular function test using multifocal electroretinography: seven prospective case studies.
111. Ultrastructural study of epiretinal membrane stained by trypan blue: 15 case reports.
112. Toxic effects of indocyanine green, infracyanine green, and trypan blue on the human retinal pigmented epithelium.
113. Cystoid macular oedema with trypan blue use.
114. A comparison of outcomes after indocyanine green and trypan blue assisted internal limiting membrane peeling during macular hole surgery.
115. Use of trypan blue to confirm the patency of filtering surgery.
116. Differential staining with indocyanine green and trypan blue dye.
117. Trypan blue staining in treatment of macular hole.
118. Trypan blue: effect on retinal pigment epithelial and neurosensory retinal cells.
119. Trypan blue staining of anteriorly placed zonules in patients with pigment dispersion.
120. Experimental study on the penetrability of trypan blue to the rat prostate.
121. Effects of trypan blue on cell viability and gene expression in human retinal pigment epithelial cells.
122. Trypan blue-assisted vitrectomy.
123. Comparison of anterior capsule electron microscopy findings with and without trypan blue stain.
124. Crystalline lens capsule staining with trypan blue.
125. Trypan blue in pediatric cataract surgery.
126. Trypan blue vital staining of the anterior lens capsule in the management of cataract in true exfoliation of the lens capsule.
127. Cystoid macular oedema with trypan blue use.
128. Trypan blue induces apoptosis in human retinal pigment epithelial cells.
129. Double visualization using triamcinolone acetonide and trypan blue during stage 3 macular hole surgery.
130. Histopathological analysis in experimental macular surgery with trypan blue.
131. Time course of lens capsule staining using trypan blue and indocyanine green: in vitro study in porcine eyes.
132. Open-sky capsulorrhexis in triple procedure: with or without trypan blue?
133. Trypan blue in macular pucker surgery: an evaluation of histology and functional outcome.
134. Trypan blue staining in vitreoretinal surgery.
135. Safety testing of indocyanine green and trypan blue using retinal pigment epithelium and glial cell cultures.
136. Comparison of the in vitro toxicity of indocyanine green to that of trypan blue in human retinal pigment epithelium cell cultures.
137. Functional outcome after trypan blue-assisted vitrectomy for macular pucker: a prospective, randomized, comparative trial.
138. Rapid and reliable DNA extraction techniques from trypan-blue-stained mycorrhizal roots: comparison of two methods.
139. Biomechanical changes in the anterior lens capsule after trypan blue staining.
140. Results of surgery on white cataract using trypan blue capsule staining to visualize capsulorrhexis.
141. Biocompatibility of trypan blue with human corneal cells.
142. Trypan blue: authors' reply.
143. Trypan blue- and indocyanine green-assisted epiretinal membrane surgery: clinical and histopathological studies.
144. Inadvertent staining of the vitreous with trypan blue.
145. Three-step technique for staining the anterior lens capsule with indocyanine green or trypan blue.
146. Iatrogenic macula hole and consequent macular detachment caused by intravitreal trypan blue injection.
147. Trypan blue has a high affinity to cellular structures such as epiretinal membrane.
148. Open-sky capsulorrhexis in triple procedure: with or without trypan blue?
149. Trypan blue staining in vitreoretinal surgery.
150. Trypan blue stains the epiretinal membrane but not the internal limiting membrane.
151. Trypan blue enhanced vitrectomy in clear gel vitrectomy.
152. Anterior and posterior capsulorhexis in pediatric cataract surgery with or without trypan blue dye: randomized prospective clinical study.
153. A histological analysis of lens capsules stained with trypan blue for capsulorrhexis in phacoemulsification cataract surgery.
154. Epiretinal membrane surgery assisted by trypan blue.
155. Trypan blue-assisted peeling of the internal limiting membrane during macular hole surgery.
156. Trypan-blue-assisted capsulorhexis for trainee phacoemulsification surgeons.
157. Double vital staining using trypan blue and infracyanine green in macular pucker surgery.
158. Trypan blue staining of the anterior capsule under an air bubble with a modified cannula.
159. In vitro assessment of the cytotoxicity of nisin, pediocin, and selected colicins on simian virus 40-transfected human colon and Vero monkey kidney cells with trypan blue staining viability assays.
160. Trypan blue assisted descemetorhexis for inadvertently retained Descemet's membranes after penetrating keratoplasty.
161. Trypan blue enhanced vitrectomy in clear gel vitrectomy.
162. A novel use for trypan blue to minimize epithelial cell proliferation in pediatric cataract surgery.
163. Contamination of trypan blue with Burkholderia cepacia in a cornea bank.
164. Why mix trypan blue with viscoelastic agents?
165. Observation of the endothelial healing in rabbit corneal alkali wounds by alizarin red S-trypan blue staining method.
166. Trypan blue not toxic for retinal pigment epithelium in vitro.
167. Deep lamellar keratoplasty with trypan blue intrastromal staining.
168. Trypan blue staining of internal limiting membrane and epiretinal membrane during vitrectomy: visual results and histopathological findings.
169. Trypan blue as an adjunct for safe phacoemulsification in eyes with white cataract.
170. Trypan-blue-stained viscoelastic material for ophthalmic surgery.
171. Trypan blue assisted phacoemulsification by residents in training.
172. Trypan blue assisted phacoemulsification in corneal opacities.
173. Trypan blue capsular staining to "find" the leading edge of a "lost" capsulorhexis.
174. Permanent blue discoloration of a hydrogel intraocular lens by intraoperative trypan blue.
175. Digital image analysis of trypan blue and fluorescein staining of anterior lens capsules and intraocular lenses.
176. Determining the lowest trypan blue concentration that satisfactorily stains the anterior capsule.
177. Deep lamellar keratoplasty with trypan blue intrastromal staining.
178. Trypan-blue-assisted posterior capsule plaque removal.
179. Trypan-blue-assisted capsulorhexis for trainee phacoemulsification surgeons.
180. Corneal endothelial cell density after trypan blue capsule staining in cataract surgery.
181. Value of two mortality assessment techniques for organ cultured corneal endothelium: trypan blue versus TUNEL technique.
182. Trypan blue staining of epiretinal membranes in proliferative vitreoretinopathy.
183. Trypan blue with a viscoelastic agent.
184. Trypan blue uptake by chinese hamster ovary cultured epithelial cells: a cellular model to study Escherichia coli STb enterotoxin.
185. Ocular toxicity study of trypan blue injected into the vitreous cavity of rabbit eyes.
186. Trypan blue mixed with sodium hyaluronate for capsulorhexis.
187. Inadvertent staining of the posterior lens capsule with trypan blue dye during phacoemulsification.
188. Evaluation of retinal damage induced by air/fluid exchange using a trypan blue inclusion test in rabbits.
189. Inhibition of formation of protease-resistant prion protein by Trypan Blue, Sirius Red and other Congo Red analogs.
190. Digitonin-permeabilization of astrocytes in culture monitored by trypan blue exclusion and loss of S100B by ELISA.
191. A microtiter trypan blue absorbance assay for the quantitative determination of excitotoxic neuronal injury in cell culture.
192. The quantitive chlorioallantoic membrane test using trypan blue stain to predict the eye irritancy of liquid scintillation cocktails.
193. Trypan blue as a slow migrating dye for SSCP detection in polyacrylamide gel electrophoresis.
194. HPC viability measurement: trypan blue versus acridine orange and propidium iodide.
195. The conformational characteristics of Congo red, Evans blue and Trypan blue.
196. Staining the lens capsule with trypan blue for visualizing capsulorhexis in surgery of mature cataracts.
197. Trypan blue capsule staining to visualize the capsulorhexis in cataract surgery.
198. The evaluation of corneal graft tissue by the use of trypan blue.
199. Changes in blood-brain barrier permeability following neurotoxic lesions of rat brain can be visualised with trypan blue.
200. Effects of trypan blue on the action of adrenergic agonists in the guinea-pig isolated atrium.
201. Simultaneous in situ detection of apoptosis and necrosis in monolayer cultures by TUNEL and trypan blue staining.
202. In situ trypan blue staining of monolayer cell cultures for permanent fixation and mounting.
203. Discrimination of apoptotic cells in flow cytometry using trypan blue and FDA.
204. P2-purinoceptor antagonists: II. Blockade of P2-purinoceptor subtypes and ecto-nucleotidases by compounds related to Evans blue and trypan blue.
205. Effect of trypan blue on the action of acetylcholine, histamine and salbutamol in the isolated guinea-pig ileum.
206. Changes in haematocrit after treatment of uncomplicated canine babesiosis: a comparison between diminazene and trypan blue, and an evaluation of the influence of parasitaemia.
207. Identification of tissue hypoxia in the livers of ascitic and hypoxia-induced broilers using trypan blue.
208. Studies on human porin: XIII. The type-1 VDAC 'porin 31HL' biotinylated at the plasmalemma of trypan blue excluding human B lymphocytes.
209. A study on the viability of corneal endothelium in rabbit by dual staining with trypan blue and alizanin red S.
210. Effect of trypan blue on the activity of lysosomal enzymes, tumor growth and cell ultrastructure in B16 melanotic melanoma in mice.
211. Blockade of P2X-purinoceptors by trypan blue in rat vas deferens.
212. Gamma-glutamyl transferase (GGT) activity and biochemical characterization of rat visceral yolk-sac during gestation with or without trypan blue exposure.
213. Effect of storage of smears on the staining of ram spermatozoa by eosin or trypan blue.
214. Direct vs. indirect effects of trypan blue on the ectodermal cells of the 11.5-day rat embryo?
215. An artifact associated with using trypan blue exclusion to measure effects of amyloid beta on neuron viability.
216. Effects of trypan blue on rat and rabbit embryos cultured in vitro.
217. Comparison of trypan blue dye exclusion and fluorometric assays for mammalian cell viability determinations.
218. The effect of oxygen supply in continuous cold perfusion of the rat liver using perfluorochemical emulsion--parenchymal and nonparenchymal cell injuries evaluated with trypan blue perfusion/fixation techniques.
219. Cytotoxicity as measured by trypan blue as a potentially confounding variable in the in vitro alkaline elution/rat hepatocyte assay.
220. Further evaluation of the quantitative chorioallantoic membrane test using trypan blue stain to predict the eye irritancy of chemicals.
221. Combined trypan blue and glyoxylic acid-induced catecholamine fluorescence in the female rat urinary bladder after distension.
222. Experimental modification of vitellogenesis in Japanese quail by trypan blue in vivo.
223. Heparin, dextran and trypan blue allosterically modulate M2 muscarinic receptor binding properties and interfere with receptor-mediated inhibition of adenylate cyclase.
224. Activation of mouse oocytes, fertilization and development of mouse embryos in vitro after staining with trypan blue or fluorescein diacetate.
225. Effect of Evans blue and trypan blue on syncytia formation and infectivity of human immunodeficiency virus type I and type II in vitro.
226. Quantitative evaluation to predict the eye irritancy of chemicals: Modification of chorioallantoic membrane test by using trypan blue.
227. On the prenatal noxious effects of trypan blue and of a related azo dye.
228. Increased attachment and confluence of skin epidermal cells in culture induced by ascorbic acid: detection by permeation of trypan blue across cultured cell layers.
229. Ultrarapid freezing and thawing of hamster oocytes. Morphologic parameters, trypan blue staining and sperm penetration assay for evaluating survival.
230. Maternal age, fertility and failure of teratogenicity by trypan blue in Jcl:SD rats.
231. Interaction of tetranectin with sulphated polysaccharides and trypan blue.
232. Trypan blue staining capacities of the culture cells (2)--The mechanism of staining.
233. Side effects of the trypanocidal chemotherapeutics trypan blue and suramin.
234. Trypan blue staining capacities of the culture cells.
235. Trypan blue in vivo stains nigral dopaminergic neurons killed by 6-hydroxydopamine.
236. Lymph node siderosis in trypan blue treated rats.
237. Strain differences in teratogenic susceptibility to trypan blue between WM and BDIX rat strains.
238. The production of cardiovascular malformations with combined use of trypan blue and anti-heart serum in the rat.
239. Malformations in rat fetuses induced by trypan blue.
240. Heat-induced K+ loss, trypan blue uptake, and cell lysis in different cell lines: effect of serum.
241. Use of trypan blue for identifying early proximal convoluted tubules.
242. Rapid selection of viable transplantable human fetal pancreatic islets by trypan blue exclusion.
243. Trypan blue and alizarin red S sequential staining with subsequent fixation. A modified technic for the study of the corneal endothelium.
244. Pasteurella haemolytica leukotoxin: comparison of 51chromium-release, trypan blue dye exclusion, and luminol-dependent chemiluminescence-inhibition assays for sensitivity in detecting leukotoxin activity.
245. Evaluation of the endothelium of human donor corneas by induced dilation of intercellular spaces and trypan blue.
246. Schistosoma mansoni: suramin and trypan blue in vitro and the ultrastructure of feeding schistosomules.
247. Photometric recording of cell viability using trypan blue in perfused cell cultures.
248. Studies on the mechanism of trypan blue teratogenicity in the rat developing in vivo and in vitro.
249. Postnatal development of offspring from pregnant rats treated with trypan blue.
250. Fetal intrauterine death and fetal malformation induced by trypan blue in rats.
251. Colorimetric determination of microgram quantities of polylysine by trypan blue precipitation.
252. Comparative pharmacokinetics of trypan blue in female Sprague-Dawley and Long-Evans rats.
253. Method of determining the area of nonperfused myocardium during coronary-occlusion ischemia using trypan blue-stained microspheres.
254. Fluorescent erythrosin B is preferable to trypan blue as a vital exclusion dye for mammalian cells in monolayer culture.
255. Trypan blue uptake as a new method to investigate hepatotoxicity in periportal and pericentral regions of the liver lobule: studies with allyl alcohol in the perfused liver.
256. Evidence for repair in trypan blue-treated mouse egg cylinders: an electron microscopic study.
257. Studies on the pharmacological bases of fetal toxicity of drugs. (VI) Teratogenic effects of trypan blue and related compounds in rats.
258. Studies on the pharmacological bases of fetal toxicity of drugs. (V) Effect of different administration routes of trypan blue in rats.
259. Abolishment of anti CFU-S and anti CFU-C activity of rabbit anti mouse brain serum (RAMBS) with trypan blue treatment of recipients.
260. Methods in laboratory investigation. Exclusion of trypan blue from microcarriers by endothelial cells: an in vitro barrier function test.
261. Ultrastructure of trypan blue-induced ocular defects II. Cornea and mesenchyme.
262. Lack of uptake of indocyanine green and trypan blue by hepatocellular carcinoma.
263. Morphological findings in lymph nodes, spleen and liver in the rat following treatment with polyvinylpyrrolidone and trypan blue (light microscopy studies).
264. Predictive value of trypan blue exclusion viability measurements for colony formation in a human tumor cloning assay.
265. Trypan blue method for the identification of areas of damage to airway epithelium due to mechanical trauma.
266. Spectrophotometric measurement of the binding of trypan blue with bovine serum proteins.
267. Assessment of adult skeletons to detect prenatal exposure to trypan blue in mice.
268. Ultrastructure of trypan blue induced ocular defects: I. Retina and lens.
269. Effects of trypan blue on thyroid secretion: localization of trypan blue within the colloid space and phagolysosomes of thyroid follicles.
270. Inactivation of measles and herpes simplex viruses by trypan blue.
271. A fluorescence quenching technique using trypan blue to differentiate between attached and ingested glutaraldehyde-fixed red blood cells in phagocytosing murine macrophages.
272. Electrocardiographic studies of developing rodents exposed in utero to trypan blue.
273. Effect of endotoxin administration in trypan blue pretreated mice.
274. A comparative study of the inhibitory effect of trypan blue on mouse erythrocyte and C3 binding receptors of peripheral blood mononuclear cells from healthy donors and patients suffering from chronic lymphocytic leukaemia.
275. Trypan blue teratogenesis in the rat: further observations in vitro.
276. Monocyte cytotoxicity: evidence for multiple mechanisms of in vitro erythrocyte target killing. Trypan blue can both inhibit and enhance target lysis.
277. Studies on the pharmacological bases of fetal toxicity of drugs. (II). Effect of trypan blue on the pregnant rats and their offspring.
278. Effects of trypan blue and related compounds on production and activity of streptolysin S.
279. The characterization of trypan blue-induced tumors in Wistar rats.
280. Trypan blue dye uptake and lactate dehydrogenase in adult rat hepatocytes--freshly isolated cells, cell suspensions, and primary monolayer cultures.
281. Dual staining of corneal endothelium with trypan blue and alizarin red S: importance of pH for the dye-lake reaction.
282. Alterations in spleen growth and sequestering function in animals receiving trypan blue.
283. Effects of trypan blue on thyroid secretion. Inhibition of purified cathepsin D from bovine thyroid.
284. Myelopoiesis in lymph nodes of mice. Enhancement effect by the injection of trypan blue or India ink after birth.
285. Vascular hypervolemia and hematoma formation in chick embryos treated with trypan blue.
286. Accumulation of DNA, RNA, and protein by cultured rat embryos following maternal administration of a teratogenic dose of trypan blue.
287. Sensitivity of mononuclear cells to PUVA: effect on subsequent stimulation with mitogens and on exclusion of trypan blue dye.
288. Development of the skeleton in normal rats and in rats with trypan blue induced spina bifida.
289. The influence of the intravenous administration of trypan blue to the choroidal tissue cells of albino rabbits (author's transl).
290. The failure of glutamic acid to protect the rat embryo against the action of trypan blue.
291. Trypan blue inhibition of complement receptor function on various cells.
292. Peripheral avian yolk assemblage and its persistence in the blastoderm, studied by trypan blue-induced fluorescence.
293. Microspectrographic analysis of trypan blue-induced fluorescence in oocytes of the Japanese quail.
294. Macrophage mediated cytotoxicity in man: role of hydrocortisone, trypan blue, chloroquine and prednisolone.
295. Ultrastructural and cytochemical effects of trypan blue on TSH stimulation of thyroid follicular cells.
296. Interrelationships between ATP levels, enzyme leakage, gluconate uptake, trypan blue exclusion and length/width ratio of isolated rat cardiac myocytes subjected to anoxia and reoxygenation.
297. Mechanism of stimulation of pinocytosis by trypan blue.
298. Per operative trypan blue vital staining of corneal endothelium. Eight years' follow up.
299. Effect of L-threonine on trypan blue-induced exencephaly.
300. Use of a trypan blue assay to measure the deoxyribonucleic acid content and radioactive labeling of viable cells.
301. The formation of caudal hematomas in trypan blue-treated chick embryos as a function of morphological stage at treatment.
302. Abnormally elevated blood pressure in the trypan blue-treated chick embryo during early morphogenesis.
303. Trypan blue staining of proteins fractionated by acrylamide disc gel electrophoresis.
304. Environmental and chemical dissociation of antibody-dependent phagocytosis from lysis mediated by macrophages: stimulation of lysis by sulfhydryl-blocking and esterase-inhibiting agents and depression by trypan blue and trypsin.
305. Specific tumor immunity induced with mitomycin C-treated syngeneic tumor cells (MCT). Effects of carrageenan and trypan blue on MCT-induced immunity in mice.
306. Ultraviolet-induced carcinogenesis in mice treated with silica, trypan blue or pyran copolymer.
307. Combination of a viability test and a quantification method for Schistosoma haematobium eggs (filtration--trypan blue-staining-technique).
308. Suppression of cell-mediated tumor cell lysis and complement-induced cytotoxicity by trypan blue.
309. Vital staining of retina and uvea with trypan blue--particularly in comparison with neutral red staining (author's transl).
310. Electron microscope observations of embryos from maternal rats treated with trypan blue.
311. Trypan Blue as a marker of plasma membrane permeability in alloxan-treated mouse islet cells.
312. The effect of trypan blue on the early control of Trypanosoma musculi parasitemia in mice.
313. Fine structural analysis of the effect of trypan blue on the visceral endoderm of the mouse egg cylinder.
314. Direct effects of trypan blue on thyroid secretion.
315. Myelopoiesis in lymph nodes of mice treated with trypan blue (author's transl).
316. Azo reduction of trypan blue to a known carcinogen by a cell-free extract of a human intestinal anaerobe.
317. The effect of trypan blue on the development of the ferret and rat.
318. Vital staining of the endothelium of preserved corneae with Trypan Blue (author's transl).
319. Effects of vinyl chloride exposure alone and in combination with trypan blue--applied systematically during all thirds of pregnancy on the fetuses of CFY rats.
320. Ultrastructural changes of the early visceral yolk sac layer of mouse embryos after maternal injection of trypan blue.
321. The induction of axial blisters in the chick embryo by trypan blue.
322. Trypan blue inhibits complement-mediated phagocytosis by human polymorphonuclear leukocytes.
323. A synergistic interaction between the teratogenic effect of trypan blue and dietary deficiency in the rat.
324. Abrogation of tumor rejection by trypan blue.
325. The use of trypan blue for counterstaining in the Sepharose bead immunofluorescence test. The application of the test for the demonstration of primate retrovirus-specific antibodies and antigens.
326. Fluorescence of Trypan blue in frozen-dried embryos of the rat.
327. Suppression of the immune response in Balb/c mice by trypan blue.
328. The effect of L-aspartic acid, L-alanine, and hemoglobin on trypan blue-induced embryolethality and gross fetal malformations in gestating albino mice.
329. An improved method for the isolation of hepatocytes from liver slices. Selective removal of Trypan blue-dyeable cells.
330. Sabouraud's medium with trypan blue as a new proposed method for the isolation and differentiation of yeasts.
331. Permeability in atherosclerosis: fluorescence test in green light with trypan blue.
332. Effects of trypan blue treatment on the immune responses of mice.
333. Modification of the Falck-Hillarp technique with intravital trypan blue to differentiate elastic fibres from noradrenergic endings proceedings.
334. Soft versus hard water as a factor in the incidence of anencephalic foetuses in litters from trypan blue treated mice.
335. Trypan blue accumulation in the embryonic gut of rats and mice during the teratogenic phase.
336. Permeability of inner and outer layers of rat and rabbit aortic wall. Two new microscopic test with trypan blue.
337. Inhibition of fibrinolytic activity of plasmin by suramin (antrypol) and trypan blue.
338. Binding and uptake of trypan blue by developing oocytes of Locusta migratoria migratorioides.
339. Alloxan cytotoxicity in vitro. Microscope photometric analyses of Trypan Blue uptake by pancreatic islet cells in suspension.
340. Permeability in atherosclerosis: a new fluorescence test with trypan blue in green light.
341. Trypan blue: identification and teratogenic and oncogenic activities of its coloured constituents.
342. Direct effects of trypan blue on cardiac extracellular macromolecule synthesis.
343. Dynamics of vitellogenin uptake in Aedes aegypti as demonstrated by trypan blue.
344. Inhibition of pinocytosis in rat yolk sac by trypan blue.
345. Chlorhexidine for irrigation of vas: a clinical trial and the study of viability of non-motile sperms in post-vasectomy patients with trypan blue uptake.
346. Effects of trypan blue on the development of the garden lizard, Calotes versicolor.
347. Radiographic changes resembling Hodgkin's disease in animals receiving trypan blue.
348. The solution behavior of the bovine myelin basic protein in the presence of anionic ligands. Binding behavior with the red component of trypan blue and sodium dodecyl sulfate.
349. Combined trypan blue and formaldehyde-induced fluorescence in experimental skin freezing in the rat.
350. Studies on the prenatally toxic effect of parathionemethyl in Wistar rats compared to cyclophosphamide and trypan blue.
351. Pathogenesis of trypan-blue-induced spina bifida.
352. Trypan blue in lymphography.
353. Disruption of normal forelimb regeneration in adult Notophthalmus viridescens by sublethal concentrations of trypan blue.
354. Investigation of trypan blue dye for determination of circulatory capacity of skeletal muscle.
355. Physiological effects of hypoxia and trypan blue in 17-day chick embryos.
356. The use of trypan blue instead of cotton blue in mycology.
357. Some additional observations relating to the mechanism of trypan blue induced teratogenesis.
358. Effect of morphine, hydromorphone, methadone, mescaline, trypan blue, vitamin A, sodium salicylate, and caffeine on the serum interferon level in response to viral infection.
359. Prevention of trypan Blue-induced exencephaly and otocephaly in gestating albino mice.
360. New muscle formation following transplantation of muscle treated with trypan blue.
361. New muscle formation following transplantation of muscle treated with trypan blue.
362. Regeneration of rabbit myocardial muscles during implantation of skeletal muscles treated with trypan blue.
363. The embryogenesis of trypan-blue induced spina bifida aperta and short tail in the rat.
364. The antiteratogenic effects of hypo- and hyperthermia in trypan blue-treated chick embryos.
365. Morphology and content of gonadotrophic hormones in the hypophysis of white mice after trypan blue injections.
366. Medium containing trypan blue and antibiotics for the detection of Cryptococcus neoformans in clinical samples.
367. Tissue kinetics study using trypan blue.
368. The effect of triton WR-1339 on the subcellular distribution of trypan blue and 125 I-labelled albumin in rat liver.
369. The effect of trypan blue on protein synthesis by maternal liver and placenta of mice.
370. Intravital uptake of trypan blue in the epithelial cells of the proximal renal tubule following sublimate intoxication and subsequent treatment with L-thyroxine (author's transl).
371. Malignant lymphoreticular tumors induced by trypan blue and transplanted in inbred rats.
372. Staining by neutral red and trypan blue in sequence for assaying vital and nonvital cultured cells.
373. Estimation of cytotoxic injury to gastric parietal cells by trypan blue exclusion test followed by hematoxylin-eosin counterstaining of fixed smears.
374. A spectrophotometric quantitation of cytotoxic action of antiserum and complement by trypan blue.
375. Effect of suramin in doses blocking trypan blue endocytosis on some enzymes in mouse liver.
376. The development of mouse blastocysts injected with, or cultured in, trypan blue solution.
377. The action of trypan blue on intraparticulate hydrolysis in liver phagolysosomes and on a lysosomal enzyme. The linking of the dye to proteins.
378. Binding of the reticuloendotheliotropic vital dye-stuffs lithium carmine and trypan blue to plasma proteins.
379. Information on the reticuloendotheliotropic vital dyes lithium carmine and trypan blue.
380. Pachometric study on the influence of corneal endothelial vital staining. Corneal thickness after cataract extraction studied by vital staining with trypan blue.
381. The influence of the fetal genome on trypan blue-induced cardiovascular defects.
382. Physiological effects of trypan blue on chick embryos.
383. Pathogenesis of trypan blue induced experimental hydrocephalus in rats.
384. Ultrastructural changes in rat livers induced by repeated injections of trypan blue.
385. Early and late effects of in vitro exposure of preimplantation mouse embryos to trypan blue.
386. Further observations on trypan blue induced antenatal neural malformations.
387. Formalin-fixed cell preparations as standards for use in the automated trypan blue cytotoxic assay.
388. Changes in permeability caused by blood vessel lipids of normal and arteriosclerotic human aortas demonstrated by the trypan blue test.
389. 51 Cr leakage from and uptake of trypan blue by target cells undergoing cell-mediated destruction.
390. Effects of hyperoxia on chick embryos injected with trypan blue.
391. The so-called red impurity of trypan blue.
392. Influence of electroconvulsions on the permeability of the blood-brain barrier to trypan blue.
393. An experimental study of trypan blue induced antenatal hydrocephalus and other neurological abnormalities in rats.
394. Pathological study on amyloidosis. A new induction method of amyloidosis by trypan blue.
395. Inhibitory action of 1-phenyl-2-(p-hydroxyphenyl)-3,5-dioxo-4n-butyl-pyrazolidine-monohydrate (oxyphenbutazone) on the capillary permeability enhancing effect of human urine irritants on ventral skin of rabbits in trypan-blue test.
396. Microscopic changes in the caudal region of the early chick embryo following the administration of trypan blue.
397. Influences of teratogenic agents on the manifestation of genetic malformations--effects of the maternal administration of trypan blue during pregnancy on the manifestation of genetic microphthalmia (mc) in mice.
398. Changes in the oestrus cycle of white mice subjected to accumulation of trypan blue in the body.
399. Trypan blue athrocytosis by rat endometrium. Morphological and dynamic data resulting from changes in the hormonal state.
400. Effect of trypan blue on growing chick embryo. II. Interference with function of the caudal morphogenetic system.
401. Histochemical studies of the nephron after application of suramin in the smallest dose blocking trypan blue endocytosis in white mouse.
402. A combined dye exclusion (trypan blue) and fluorochromatic technique for the microdroplet lymphocytotoxicity test.
403. Investigation of the cytotoxicity of different trypan blue commercial products.
404. Deformities of the renal tract associated with spina bifida in trypan blue treated rat embryos.
405. The influence of trypan blue, Niagara blue 2B, and colloidal carbon on the absorption and transport of valine by rat intestinal segments.
406. Results of selection for susceptibility and resistance to trypan blue teratogenesis in a four-way outcross mouse population.
407. Utilization of trypan blue in clinical dentistry.
408. Trypan blue: reaction with myelin.
409. Staining of pathogenic fungi with trypan blue.
410. Interaction of lactoferrin with agar gels and with Trypan Blue.
411. Intraperitoneal trypan blue as a means to visualize cutaneous anaphylaxis.
412. The effects of trypan blue on the blood pressure of rat embryos.
413. Uptake of trypan blue and ferritin into the "Globular Cells" of the connective tissue of Helix pomatia and Cepaea nemoralis (Stylommatophora, Pulmonata).
414. The significance of the yolk sac placenta for the development of malformations due to trypan blue and lithium carmine.
415. The effect of Trypan Blue, suramin and aurothiomalate on the breakdown of 125 I-labelled albumin within rat liver lysosomes.
416. Teratogenic property of trypan blue in the chick embryo.
417. Effect of trypan blue on metabolic and phagocytic activity of alveolar macrophages.
418. Malformations caused in mouse embryos by a red dye contained in commmerical trypan blue.
419. The red impurity in trypan blue.
420. Teratogenic effects of direct injection of aqueous and protein-bound trypan blue into the bloodstream of 3-day chick embryos.
421. Influence of age and sex on chronic thyroiditis in rats given subcutaneous injections of trypan blue.
422. A technique for detection of agglutinating activity of antilymphocytic serum using formalinized and trypan-blue-stained lymphocytes.
423. The effect of trypan blue on expressivity of the brachyury gene, "T," in mice.
424. Trypan blue and the extra-toes locus in the mouse.
425. Trypan blue-induced deletions in duplication strains of Aspergillus nidulans.
426. Congenital anomalies in the pig: teratogenic effects of trypan blue.
427. The effect of trypan blue on the growth of the rat embryo in vivo.
428. Trypan blue inhibition of yolk deposition--a clue to follicle cell function in the cecropia moth.
429. Postnatal sequences of myelodysplasia in the rat offspring caused by maternal administration of trypan blue during pregnancy.
430. The morphogenesis of developmental malformations of the central nervous system. IV. The earliest morphologic changes within embryonic tissue after application of trypan blue.
431. Embryotoxic dose-response relations of trypan blue in mice.
432. Embryotoxic actions of trypan blue in mice as a function of time of administration.
433. Fixation and absorption of trypan blue by the young chick embryo.
434. Effects of trypan blue and Niagara blue 2B on the in vitro absorption of ions by the rat visceral yolk sac.
435. The effect of teratogenic doses of trypan blue on the yolk sac placenta of the mouse. A histological and histochemical study.
436. Congo red and trypan blue as stains for plaque assay of newcastle disease virus.
437. Comparative teratogenicity of isoproterenol and trypan blue in the fetal hamster.
438. The effect of trypan blue on the hepatotoxicity of carbon tetrachloride in the rat.
439. Protein digestion in isolated lysosomes inhibited by intralysosomal trypan blue.
440. Thyroiditis in rats given subcutaneous injections of trypan blue.
441. Investigation on resorption of the endolymph in the inner ear of the guinea pig. I. Microscopic examinations after injection of trypan blue into the cochlear duct.
442. Peculiarities of reticulosis due to trypan blue injections in castrated male rats.
443. Concurrent registration of EEG responses, catecholamine uptake and trypan blue staining in chemical blood-brain-barrier damage.
444. Oxygen consumption in normal and trypan blue-treated chick embryos.
445. The effects of trypan blue on rat liver heterolysosomes.
446. Studies of local immunity by staphylococcal toxin. 3. Skin reactions and the activities of the antibodies at subcutaneous injection of staphylococcal toxin in rabbits treated with anti-rabbit-lymphatic tissue serum or trypan blue.
447. Trypan blue and the generalized Shwartzman reaction. The nature and formation of fibrinoid material in the pulmonary arteries.
448. Permeability of the placental barrier with regard to hemolytic staphylococci and trypan blue.
449. Trypan blue in the rat embryo.
450. Chromosome aberrations in trypan blue induced teratogenesis in mice.
451. Analysis of trypan blue induced teratogenesis in Rana pipiens embryos.
452. Permeability of the walls of umbilical cord vessels. II. Estimation of factors, influencing the speed of the permeation of water, glucose, trypan blue, chloride, sodium and potassium through the cord vessel walls to the medium.
453. Permeability of the walls of umbilical cord vessels. I. Determination of the permeability of cord arteries and veins to water, glucose, trypan blue, chloride, sodium and potassium.
454. Cytophotometric measurements of DNA in retinal cell nuclei in rat foetuses with trypan blue-induced unilateral anophthalmia.
455. Effects of maternal genotype and treatment history on response to trypan blue.
456. Penetration of intravenous trypan blue into the rat testis and epididymis.
457. Trypan blue incorporation by rat ovary.
458. An analysis of the growth retarding effects of trypan blue in the albino rats.
459. Lysosomal enzyme inhibition by trypan blue: a theory of teratogenesis.
460. Analysis of trypan blue-induced rumplessness in chick embryos.
461. Spectrophotometric studies of the binding of trypan blue to bovine serum albumin.
462. Behavior of the rabbit circumventricular organsfllowing intravenous administration of trypan blue.
463. Effects of position in the uterus on fetal mortality and on response to trypan blue.
464. Vital staining with neutral red and trypan blue of 3H-thymidine-labeled cells prior to autoradiography.
465. Further observations on resorption in guinea pigs following injections of trypan blue.
466. Localization of radioiodinated endotoxin in organs of mice and rabbits: effect of thorotrast, trypan blue, endotoxin and carbon administered intravenously.
467. Storage capcity of the liver for trypan blue following prolonged hypoxydosis.
468. Comparative histochemical studies of the retina in rat fetuses, normal and with unilateral anophthalmia induced with trypan blue.
469. Trypan blue. Vital staining of cornea and conjunctiva.
470. Malformations of upper incisors in mouse embryos with exencephaly, induced by trypan blue.
471. Effects of trypan blue on hepatocarcinogenesis in rats given ethionine or N-2-fluorenylacetamide.
472. Transposition of the great vessels and other cardiovascular abnormalities in rat fetuses induced by trypan blue.
473. Trypan blue induced teratogenesis of rat embryos cultivated in vitro.
474. Teratogenic action of the thyroid stimulating hormone and its interaction with trypan blue.
475. Cytopathic effect of humoral antibodies against fibroblasts. The protective action of heparin and trypan blue.
476. Influence of thyroid function on the teratogenic activity of trypan blue in the rat.
477. The effect of trypan blue on the postnatal development of serum proteins.
478. Observations on the penetration and uptake of trypan blue in embryonic membranes of the mouse.
479. Uptake of catecholamines and penetration of trypan blue after blood-brain barrier lesions. A histochemical study.
480. Inhibition of erythropoiesis. 3. The influence of trypan blue on erythropoiesis as investigated by the tracer technique.
481. Intravital and postmortem studies on air embolism damage of the blood-brain barrier tested with trypan blue.
482. The morphogenesis of developmental malformations of the central nervous system. II. Relationship between changes in protein metabolism and development of malformations after application of trypan blue.
483. Transplantation of rat reticulosarcomas following trypan blue injections.
484. Septal abnormalities induced by trypan blue in rat embryos.
485. Histochemical studies of nucleic acids and glycogen in the liver cells of rats treated with trypan blue and Evans blue.
486. Teratogenic effects of synthetic compounds related to trypan blue: the effect of 1,7-diamino-8-naphthol-3,6-disulphonic acid on pregnancy in the rat.
487. Teratogenic effects of trypan blue on Cotrunix quail when injected into the mother.
488. Vital staining by trypan blue; its selectivity for olfactory receptor cells of the brown bullhead, Ictalurus natalis.
489. Teratogenic effect of trypan blue on rat embryos cultivated in vitro.
490. STUDIES ON THE EFFECT OF TRYPAN BLUE IN THE PREGNANT ARMADILLO, DASYPUS NOVEMCINCTUS.
491. THE EFFECT OF BACTERIAL PYROGEN ON THE BLOOD-BRAIN BARRIER FOR TRYPAN BLUE.
492. FURTHER STUDIES ON THE MECHANISM OF ACTION OF TRYPAN BLUE AND RELATED DYES IN SUPPRESSING THYROID ACTIVITY IN THE RAT.
493. MORPHOLOGICAL AND PHYSIOLOGICAL EFFECTS OF THALIDOMIDE AND TRYPAN BLUE ON UTERI AND CONCEPTI OF GRAVID MICE.
494. Comparative intravital and postmortem studies on chemically induced blood-brain barrier damage tested with trypan blue.
495. PHENOL RED EXCRETION AND TRYPAN BLUE UPTAKE IN LEAD NEPHROPATHY OF THE RAT.
496. EVALUATION OF THE TRYPAN BLUE TECHNIQUE FOR DETERMINATION OF CELL VIABILITY.
497. SUB-LINE DIFFERENCES AMONG C57 BLACK MICE IN RESPONSE TO TRYPAN BLUE AND OUTCROSS.
498. HISTOLOGIC TECHNIQUE FOR TISSUES STAINED WITH TRYPAN BLUE.
499. EFFECT OF TRYPAN BLUE ON THE ELIMINATION OF DUST FROM THE LUNGS.
500. THE TERATOGENIC ACTIVITY OF TRYPAN BLUE, AND ITS EFFECT ON THE THYRO-HYPOPHYSEAL AXIS IN THE RAT.
501. STUDIES ON THE MECHANISM OF TRYPAN BLUE-INDUCED CONGENITAL MALFORMATIONS. I. DYE FRACTIONS AND FETAL ANOMALIES.
502. THE ACRIDINE ORANGE VIABILITY TEST APPLIED TO BONE MARROW CELLS. I. CORRELATION WITH TRYPAN BLUE AND EOSIN DYE EXCLUSION AND TISSUE CULTURE TRANSFORMATION.
503. ETIOLOGY OF TRYPAN BLUE INDUCED ANTENATAL HYDROCEPHALUS IN THE ALBINO RAT.
504. DOSAGE-RESPONSE CURVES FOR THE TERATOGENIC ACTIVITY OF TRYPAN BLUE.
505. STUDIES ON THE TERATOGENIC PROPERTIES OF TRYPAN BLUE AND ITS COMPONENTS IN MICE.
506. STUDIES ON THE PROBLEM OF IMMEDIATE DEMONSTRATION OF BIOLOGIC EFFECTS OF ROENTGEN RAYS. 5. ON THE TRYPAN BLUE REACTION OF THE SKIN FOLLOWING ROENTGEN IRRADIATION.
507. THE MORPHOGENESIS OF DEVELOPMENTAL MALFORMATIONS OF THE CENTRAL NERVOUS SYSTEM. I. THE INFLUENCE OF TRYPAN BLUE ON THE DEVELOPMENT OF THE FETUS.
508. Study on micromelias in the mouse fetus caused by x-radiation, hypoxia, trypan blue injection of hypervitaminosis-A upon mother animals during pregnancy.
509. Hemodynamic effects of shock doses of histamine and trypan blue during ethyl alcohol intoxication in dogs.
510. ELECTRON MICROSCOPIC OBSERVATIONS ON THE PASSAGE OF ELECTROLYTE SOLUTIONS AND TRYPAN BLUE FLUID THROUGH THE WALLS OF VENULES AND CAPILLARIES OF THE VENOUS SIDE.
511. THE SITE OF ACTION OF TRYPAN BLUE IN CARDIAC TERATOGENESIS.
512. SUBCUTANEOUS NEOPLASMS INDUCED BY TRYPAN BLUE.
513. INFLUENCE OF TRYPAN BLUE ON RESORPTION OF RAT EMBRYOS.
514. STUDIES ON SERUM PROTEIN CHANGES AND ORGAN DYE CONCENTRATION IN TRYPAN BLUE CARCINOGENESIS.
515. THE EFFECT OF TRYPAN BLUE ON THE SERUM PROTEINS OF THE FETAL RAT.
516. EFFECTS OF PH ON POST-MORTEM RETENTION OF TRYPAN BLUE VITAL STAINING IN TISSUES OF MICE.
517. ACTION OF TRYPAN BLUE ON THE CELLS OF THE YOUNG CHICK EMBRYO.
518. EFFECT OF THE USE OF TRYPAN BLUE AND MERCAPTOPURINE ON TAKES OF HOMOGENOUS SKIN GRAFTS IN THE RAT.
519. The effects of trypan blue on the formation of thrombi in the generalised Shwartzman reaction.
520. THE EFFECT OF CARBON DIOXIDE INHALATION ON PHOSPHORUS METABOLISM OF THE BRAIN--AN EXPERIMENTAL STUDY WITH RADIOAUTOGRAPHY, VITAL STAINING WITH TRYPAN BLUE, AND ELECTRON MICROSCOPY.
521. SARCOMAS AT THE SITE OF SUBCUTANEOUS INJECTION OF TRYPAN BLUE IN WISTAR RATS. HISTOLOGICAL AND CYTOLOGICAL STUDIES.
522. Morphology of defects of the neurovertebral axis caused by trypan blue in rats.
523. The preparation and teratogenic properties of pure trypan blue and its common contaminants.
524. INTRADERMAL TEST WITH TRYPAN BLUE IN CHILDREN AFTER BCG REVACCINATION BY THE INTRADERMAL METHOD.
525. SUBCUTANEOUS NEOPLASMS INDUCED BY TRYPAN BLUE.
526. Studies on hemolysin production in trypan blue-treated rats.
527. INTRADERMAL TRYPAN BLUE TEST AS A CRITERION IN THE EVALUATION OF THE STABILIZATION OF TUBERCULOSIS.
528. Absence of teratogenic action of trypan blue in pregnant rats when implantation is retarded by simultaneous lactation.
529. A quantitative method for the study of capillary permeability: extraction and determination of trypan blue in tissues.
530. An embryological study of the myeloschisis on rat induced by trypan blue.
531. Interference of Niagara blue 2B with the teratogenic action of trypan blue.
532. Electrophoretic pattern of plasma proteins in rats treated with trypan blue and ethionine.
533. Action of flavonoids on the intradermal diffusion of trypan blue.
534. Studies on the blood-brain barrier in hypothermia. An experimental investigation in the rabbit with special reference to the effect of intracarotid injection of iodopyracet on the passage of trypan blue into the brain parenchyma.
535. Changes in the reticuloendothelial system of adrenalectomized rats after intraperitoneal injections of trypan blue, cortisone and DOCA.
536. 1st reactions to trypan blue of the chick embryo during gastrulation.
537. Failure of trypan blue to inhibit the thyrotrophic activity of the adenohypophysis in methylthiouracil-fed rats.
538. Protection of chick embryos against Newcastle disease virus by Trypan blue and other compounds.
539. Comparison of the different teratogenic effects of three commerical samples of trypan blue.
540. Time of teratogenic action of trypan blue in guinea pigs.
541. Anemia with positive direct Coombs' test induced by trypan blue.
542. Anemia with positive direct Coombs' test induced by trypan blue.
543. An embryological analysis of certain cardiac abnromalities produced in rats by the injection of trypan blue.
544. Teratogenesis due to hypervitaminosis A in combination with other teratogenic factors (cortisone, trypan blue, noise-stimulation,urethan and chondroitinsulfate).
545. Reactions of chick embryo to trypan blue.
546. Chromatographic separation of biologically active components from commercial trypan blue.
547. Electron-microscopic studies on the choroid. I. Findings of albino rabbit choroid by vital staining with combination of india-ink and trypan blue, with special reference to the phagocyte containing carbon particles.
548. Complement-dependent effect of normal rabbit serum on trypan blue staining, morphology, and viability of cultured Walker 256 tumor cells.
549. Alkaline ribonuclease activity increase in rat kidney cortex and liver after trypan blue and other azo dyes administration.
550. Experimental induction of Arnold-Chiari deformity by Trypan blue.
551. On experimental induction of heart abnormalities by Trypan blue.
552. Proliferation of the reticulohistiocytic system in rats after the administration of trypan blue.
553. Trypan blue concentration and protein composition in sera of rats injected repeatedly with Trypan blue in relation to reticulosis and to reticulosarcoma.
554. Regeneration of serum proteins and serum glycoproteins in rabbits subjected to bleeding and simultaneous poisoning with trypan blue.
555. Effect of trypan blue on rat embryos.
556. The effect of trypan blue on thyroid function in the rat.
557. Mechanism of action of trypan blue in suppressing thyroid function.
558. Teratogenic activity of several synthetic compounds structurally related to trypan blue.
559. The effects of trypan blue on chick embryos cultured in vitro.
560. Intracellular effect of abiogenic colloids. Elimination of trypan blue by polyvinylpyrrolidone in vitally stained frog heart.
561. Acute stimulation of the reticuloendothelial system of rats with trypan blue.
562. On the anaphylactic reaction on the isolated auricle and duodenum of the sensitized guinea pig after trypan blue and gold diaspore treatment.
563. Electron microscopic studies on the uptake of trypan blue in the cells of the main segment of the kidney.
564. Comparative evaluation of certain indices of the organism in pulmonary tuberculosis (according to data on trypan blue skin test and erythrocyte sedimentation reaction and the determination of lymphocytes and monocytes).
565. Action of chlorpromazine on the intradermal diffusion of trypan blue.
566. Research on the reparative processes in the lymphatic tissues of animals irradiated with lethal doses and exposed to hemopoietic tissue grafting. II. The reparative processes in the spleen of rats irradiated and treated with suspensions of splenic cells of rats treated with trypan blue.
567. Inhibiting effect of a prophylactically admiistered adrenalin on immediate hypotensive effects of trypan blue in dye shock in cats.
568. Abnormal serum protein observed in trypan blue-treated rats.
569. Effect of trypan blue upon distribution of metastases and transplants of rabbit VX2 and Walker rat 256 tumors.
570. Report of malformations produced by trypan blue.
571. The effect of trypan blue upon maternal protein metabolism and embryonic development.
572. Reaction of reticular tissue in guinea pigs after administration of foreign blood serum and trypan blue.
573. Studies on the mechanism of teratogenic action of trypan blue.
574. Intracutaneous trypan blue tests in pulmonary tuberculosis.
575. Observations on the use of the trypan blue and skin-twitch tests for measuring local tissue toxicity.
576. Effect of trypan blue block of reticuloendothelial system on corticoid elimination in the cat.
577. Teratogenic action of trypan blue in the pregnant rat & hormonal regulation of the mechanism during pregnancy.
578. Effects of certain compounds related to trypan blue on the experimental production of liver cancer.
579. Teratogenic effects of trypan blue on hamster embryos.
580. Staining reactions of some anionic disazo dyes and histochemical properties of the red impurity in trypan blue.
581. Paper chromatography of anionic disazo dyes, especially trypan blue and its red impurity.
582. Effects of trypan blue on the tentacular regeneration blastema of Arion rufus L.
583. Experimental production of cardiovascular anomalies in dogs using trypan blue.
584. Progressive reticulosis of the rat after high doses of trypan blue.
585. Trypan blue in the rabbit.
586. Teratogenic effect of trypan blue on the developing chick.
587. The influence of carbon dioxide inhalation on the cerebral vascular permeability to trypan blue (the blood-brain barrier).
588. Production and inhibition of hepatic sarcomata in rats by injections of trypan blue.
589. Subcutaneous transplantation of epithelial tissues of fetuses or young animals; pretreatment of grafts with trypan blue.
590. Biochemical interaction of trypan blue and p-dimethylaminoazobenzene in the liver of rat. II. The inhibitory effect of trypan blue on the experimental production of liver carcinoma.
591. The influence of systematically administered trypan blue on prenatal development of rats and mice.
592. Possibility of epithelial metaplasia of fibrocytes in subcutaneous grafts of the gastric mucosa treated with trypan blue.
593. Comparison between intradermic diffusion of India ink, Evans blue & Trypan blue; diffusion in living & dead rabbit.
594. The carcinogenicity of certain compounds related to trypan blue.
595. Trypan blue induced anomalies in the genito-urinary system of rats.
596. Chlorazol fast pink B and trypan blue tests for virus and other proteinaceous inclusions.
597. Developing blood brain barrier to trypan blue.
598. Teratogenic effect of trypan blue in the rat.
599. The effects of repeated injections of trypan blue in rats; goitrogenic action.
600. The so-called reticuloendothelial system block with trypan blue.
601. Findings in the rats after prolonged experiments with intraperitoneal injections of trypan blue.
602. Spina bifida and the Arnold-Chiari malformation in the progeny of trypan blue injected rats.
603. Permeability of the rabbit blastocyst to trypan blue.
604. Biochemical interaction of trypan blue and p-dimethylaminoazobenzene in the liver of rat.
605. Studies on the haematological reactions produced in rats by prolonged treatment with trypan blue. I. Quantitative haematological data.
606. Partial inhibition of the serum cholinesterase activity in dogs by injection of trypan blue; theory concerning the origin and function of serum cholinesterase.
607. Change in the cholinesterase and acetylcholine activity of the blood during trypan blue and trypan red therapy of demyelinizing diseases of the brain and spinal cord.
608. Trypan blue as stain for fungi.
609. Reticulumcell sarcoma of rats; experimental production with trypan blue.
610. Carcinogenic effect of the azo dyes, Evans blue and trypan blue, on the reticuloendothelial system of the liver.
611. Trypan blue and red in therapy of demyelinating diseases of the neuraxis.
612. Teratogenic activity of several azo dyes chemically related to trypan blue.
613. The influence of Aerobacter levan on the permeability of the blood vessels of the skin: studies with antibody globulins and trypan blue.
614. Effects of various compounds on the Yoshida sarcoma cells; on the nuclear-staining with congo red and trypan blue.
615. Effect of trypan blue and trypan red on the carcinogenesis of rats fed DAB.
616. Vital staining of calcifying bone and dentin with trypan blue.
617. Inhibiting effect of trypan blue on the experimental production of liver cancer.
618. Course of experimental hemolytic anemia in splenectomized or trypan blue pre-treated rats.
619. The morphogenesis of trypan blue induced defects of the eye.
620. Sex differences of various histological reactions in the rat to trypan blue injections.
621. Effect of trypan blue injection on the incidence of liver carcinoma in rats fed p-dimethylaminoazobenzene. II.
622. Effect of trypan blue on the carcinogenesis of rats fed DAB.
623. The embryology of trypan blue induced abnormalities in mice.
624. Trypan blue and furaspor concentrate in the treatment of demodectic mange.
625. Possible determination of the vitality of tumor cells on the basis of trypan blue storage.
626. Findings in retothelia system in rat following short trials with intraperitoneal injections of trypan blue.
627. The effect of ergot alkaloids and narcosis (avertin) on rat edema of the paw and lungs after bilateral vagotomy and the characterization of the said edemas by trypan blue.
628. Effect of experimental block of reticuloendothelial system with trypan blue and iron saccharate on anoxemic resistance in rat.
629. Trypan blue as a nuclear stain for plant material.
630. Comparison of haematological reactions to injections of dextran, Trypan blue and saponin.
631. Influence of trypan blue on the number of circulating eosinophils in rats.
632. Effect of vitamin B1 on the course of trypan blue shock.
633. Trypan blue test in pulmonary tuberculosis.
634. A further report on congenital anomalies in the rat produced by trypan blue.
635. Studies on the generalized Shwartzman reaction. II. The production of bilateral cortical necrosis of the kidneys by a single injection of bacterial toxin in rabbits previously treated with thorotrast or trypan blue.
636. Trypan blue-induced tumours of rats.
637. Effect of trypan blue on sensitivity to 1-chloro-2-4-dinitrobenzene.
638. Spectrophotometric studies on the combination of trypan blue and related dyes with the plasma albumin of the rat, guinea pig and the baboon.
639. Effect of injected lyophilized tumor and trypan blue on host resistance to tumor grafts.
640. Effect of oestradiol benzoate and orchidectomy on the toxicity of trypan blue.
641. Vital staining of the hematoencephalic barrier by silver nitrate and trypan blue, and cytological comparisons of the neurohypophysis, pineal body, area postrema, intercolumnar tubercle and supraoptic crest.
642. Trypan blue and trypan red in the treatment of amyotrophic lateral sclerosis; application to the treatment of multiple sclerosis.
643. Trypan blue vital staining.
644. The effect of trypan blue on susceptibility to histamine.
645. Malformations in mouse embryos induced by trypan blue.
646. Malformations in mouse embryos induced by trypan blue.
647. Experimental granuloma obtainable and transmissible from carbon tetrachloride and trypan blue.
648. Tissue cultures in the presence of trypan blue.
649. Effect of cortisone on the treatment of experimental trypanosomiasis with trypan blue.
650. Popoff's trypan blue therapy of Duhring's disease.
651. Leukopoiesis in trypan blue treated rats and its implications for the understanding of human leukaemias.
652. The cytology of the leukocytes in the blood of albino rats and comparisons with leukocytes in the blood of trypan blue-treated rats.
653. Production of cold agglutinins in response to trypan blue as a reticuloendothelial function test.
654. Effects of ACTH on the mechanism of increased capillary permeability to trypan blue in inflammation.
655. Effects of cortisone on the mechanism of increased capillary permeability to trypan blue in inflammation.
656. Preliminary note on therapy of multiple sclerosis with trypan blue and red.
657. Trial therapy of amyotrophic lateral sclerosis with trypan blue and red; first results in 11 cases.
658. Analogous effects of radiation and trypan blue on rats resistant to transplanted hepatoma.
659. Cellular proliferation seen in the portal spaces of albino rats stained vitally by trypan blue.
660. The effect of trypan blue and congo red on the heart and blood vessels of the frog.
661. Experimental congenital hydrocephalus following treatment with trypan blue.
662. Use of the trypan blue and rabbit eye tests for irritation.
663. Barrier permeability of the cerebrospinal cavity to trypan blue, with special reference to acute oxygen deficiency.
664. Effect of antihistamine on the localization of trypan blue in xylene treated areas of skin.
665. The distribution of radioactivity in tumor-bearing mice after injection of radioactive iodinated trypan blue.
666. Passage of trypan blue into the endolymphatic system of the labyrinth.
667. A preliminary report on hydrocephalus, spina bifida and other congenital anomalies in the rat produced by trypan blue; the significance of these results in the interpretation of congenital malformations following maternal rubella.
668. Absorption of trypan blue from the human knee joint.
669. The storage of vital stains (trypan blue, vital new red) in the rabbit endocardium.
670. The influence of choline and of trypan blue upon the utilization of carotene and vitamin A for liver storage of Vitamin A.
671. Skin test with trypan blue for the estimation of connective tissue reactivity in roentgentherapy of cancer.
672. Skin test with trypan blue in cancer patients.
673. Leshchinsky's reaction with trypan blue as characteristic of the functional condition of the reticulo-endothelial system of the skin in cutaneous tuberculosis.
674. STUDIES WITH RADIOACTIVE DI-AZO DYES. II. THE SYNTHESIS AND PROPERTIES OF RADIOACTIVE DI-BROM TRYPAN BLUE AND RADIOACTIVE DI-BROM EVANS BLUE.
675. Storage of trypan blue in the heart valves of the rabbit.
676. STUDIES WITH RADIOACTIVE DI-AZO DYES. 1. THE LOCALIZATION OF RADIOACTIVE DI-BROM TRYPAN BLUE IN INFLAMMATORY LESIONS.
677. Trypan-blue Vital Staining in Studies of Virus Lesions on Chorio-allantoic Membrane.
678. The Uterus of Cavia after Intravitam Staining with Trypan Blue.
679. STUDIES ON INFLAMMATION : VI. FIXATION OF TRYPAN BLUE IN INFLAMED AREAS OF FROGS.
680. Intravital Staining of Microglia with Trypan Blue.
681. ALLERGIC IRRITABILITY : III. THE INFLUENCE OF CHRONIC INFECTIONS AND OF TRYPAN BLUE ON THE FORMATION OF SPECIFIC ANTIBODIES.